Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 385

1.

In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype.

Hotz B, Keilholz U, Fusi A, Buhr HJ, Hotz HG.

Gastric Cancer. 2012 Jul;15(3):252-64. doi: 10.1007/s10120-011-0102-9. Epub 2011 Oct 20.

PMID:
22011788
[PubMed - indexed for MEDLINE]
2.

Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation.

Patel D, Bassi R, Hooper A, Prewett M, Hicklin DJ, Kang X.

Int J Oncol. 2009 Jan;34(1):25-32.

PMID:
19082474
[PubMed - indexed for MEDLINE]
3.

[EGFR-blockade by antibody Cetuximab inhibits the growth of human gastric cancer xenograft in nude mice and its possible mechanism].

Zhang J, Ji J, Yuan F, Ma T, Ye ZB, Yu YY, Liu BY, Zhu ZG.

Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):85-9. Chinese.

PMID:
19538880
[PubMed - indexed for MEDLINE]
4.

Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor.

Steiner P, Joynes C, Bassi R, Wang S, Tonra JR, Hadari YR, Hicklin DJ.

Clin Cancer Res. 2007 Mar 1;13(5):1540-51.

PMID:
17332300
[PubMed - indexed for MEDLINE]
Free Article
5.

Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity.

Hara M, Nakanishi H, Tsujimura K, Matsui M, Yatabe Y, Manabe T, Tatematsu M.

Cancer Sci. 2008 Jul;99(7):1471-8. doi: 10.1111/j.1349-7006.2008.00821.x. Epub 2008 Apr 16.

PMID:
18422755
[PubMed - indexed for MEDLINE]
6.

Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.

Matar P, Rojo F, Cassia R, Moreno-Bueno G, Di Cosimo S, Tabernero J, Guzmán M, Rodriguez S, Arribas J, Palacios J, Baselga J.

Clin Cancer Res. 2004 Oct 1;10(19):6487-501.

PMID:
15475436
[PubMed - indexed for MEDLINE]
Free Article
7.

Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan.

Liu X, Guo WJ, Zhang XW, Cai X, Tian S, Li J.

Cancer Chemother Pharmacol. 2011 Oct;68(4):871-8. doi: 10.1007/s00280-011-1559-2. Epub 2011 Feb 1.

PMID:
21286718
[PubMed - indexed for MEDLINE]
8.

Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.

Lee J, Lee I, Han B, Park JO, Jang J, Park C, Kang WK.

J Natl Cancer Inst. 2011 Apr 20;103(8):674-88. doi: 10.1093/jnci/djr070. Epub 2011 Mar 11.

PMID:
21398618
[PubMed - indexed for MEDLINE]
Free Article
9.

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.

Dunn EF, Iida M, Myers RA, Campbell DA, Hintz KA, Armstrong EA, Li C, Wheeler DL.

Oncogene. 2011 Feb 3;30(5):561-74. doi: 10.1038/onc.2010.430. Epub 2010 Oct 18.

PMID:
20956938
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor.

Freeman DJ, Bush T, Ogbagabriel S, Belmontes B, Juan T, Plewa C, Van G, Johnson C, Radinsky R.

Mol Cancer Ther. 2009 Jun;8(6):1536-46. doi: 10.1158/1535-7163.MCT-08-0978. Epub 2009 Jun 9.

PMID:
19509246
[PubMed - indexed for MEDLINE]
Free Article
11.

Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.

Harding J, Burtness B.

Drugs Today (Barc). 2005 Feb;41(2):107-27. Review.

PMID:
15821783
[PubMed - indexed for MEDLINE]
12.

Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo.

Hsu YF, Ajona D, Corrales L, Lopez-Picazo JM, Gurpide A, Montuenga LM, Pio R.

Mol Cancer. 2010 Jun 7;9:139. doi: 10.1186/1476-4598-9-139.

PMID:
20529262
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).

Correale P, Marra M, Remondo C, Migali C, Misso G, Arcuri FP, Del Vecchio MT, Carducci A, Loiacono L, Tassone P, Abbruzzese A, Tagliaferri P, Caraglia M.

Eur J Cancer. 2010 Jun;46(9):1703-11. doi: 10.1016/j.ejca.2010.03.005.

PMID:
20399639
[PubMed - indexed for MEDLINE]
14.

The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.

Raben D, Helfrich B, Chan DC, Ciardiello F, Zhao L, Franklin W, Barón AE, Zeng C, Johnson TK, Bunn PA Jr.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):795-805.

PMID:
15701870
[PubMed - indexed for MEDLINE]
Free Article
15.

Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases.

Morelli MP, Cascone T, Troiani T, Tuccillo C, Bianco R, Normanno N, Romano M, Veneziani BM, Fontanini G, Eckhardt SG, De Pacido S, Tortora G, Ciardiello F.

J Cell Physiol. 2006 Aug;208(2):344-53.

PMID:
16688779
[PubMed - indexed for MEDLINE]
16.

Antitumor effect of cetuximab in combination with S-1 in EGFR-amplified gastric cancer cells.

Fukuda K, Saikawa Y, Takahashi M, Takahashi T, Wada N, Kawakubo H, Takeuchi H, Kitagawa Y.

Int J Oncol. 2012 Apr;40(4):975-82. doi: 10.3892/ijo.2011.1279. Epub 2011 Dec 1.

PMID:
22139134
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Combination effect of cetuximab with radiation in colorectal cancer cells.

Shin HK, Kim MS, Lee JK, Lee SS, Ji YH, Kim JI, Jeong JH.

Tumori. 2010 Sep-Oct;96(5):713-20.

PMID:
21302618
[PubMed - indexed for MEDLINE]
18.

In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.

Balin-Gauthier D, Delord JP, Rochaix P, Mallard V, Thomas F, Hennebelle I, Bugat R, Canal P, Allal C.

Cancer Chemother Pharmacol. 2006 Jun;57(6):709-18. Epub 2005 Dec 1.

PMID:
16320055
[PubMed - indexed for MEDLINE]
19.

Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines.

Kneissl J, Keller S, Lorber T, Heindl S, Keller G, Drexler I, Hapfelmeier A, Höfler H, Luber B.

Int J Oncol. 2012 Aug;41(2):733-44. doi: 10.3892/ijo.2012.1479. Epub 2012 May 14.

PMID:
22614881
[PubMed - indexed for MEDLINE]
20.

Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.

Park SJ, Kim MJ, Kim YK, Kim SM, Park JY, Myoung H.

Cancer Lett. 2010 Jun 1;292(1):54-63. doi: 10.1016/j.canlet.2009.11.004. Epub 2009 Dec 2.

PMID:
19959278
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk